Dark

VTGN
Vistagen Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Sep 23, 2026 3:59:17 PM EDT

0.3600USD+44.193%(+0.1111)571,374,527

0.3100Bid 0.4200Ask 0.1100Spread

Pre-market

Sep 23, 2026 9:29:30 AM EDT

0.3911USD+55.569%(+0.1397)15,138,363

After-hours

Sep 23, 2026 4:59:30 PM EDT

0.3684USD+1.628%(+0.0059)731,749

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

16.31M

Headquarters

CA, USA

Industry

Biotechnology

Next Earnings

Nov 12, 2026 (50d)

Last Split

Jun 7, 20231for30reverse

GNCA IOVA XLV

VTGN Stats

Avg. Vol. 10 Day

986,069

Avg. Vol. 30 Day

774,417

Market Cap

16,312,952

Shares Out.

44,376,911

On/Off Exchange

40%/60%

6 Month Beta

1.12

1 Year Beta

1.63

2 Year Beta

1.00

3 Year Beta

1.07

52 Week Low

0.20

52 Week High

5.14

SMA50

0.25

SMA200

0.68

1 Week

+59.41%

1 Month

+50.78%

3 Month

-41.86%

6 Month

-40.36%

1 Year

-89.31%

2 Year

-87.87%

5 Year

-99.59%

Profile

we have developed a versatile stem cell technology platform based on the controlled differentiation of human pluripotent stem cells into mature, non-transformed, human cells which can be used to create novel bioassay systems for predictive toxicology, drug metabolism screening, drug discovery, drug rescue and cell therapy. we believe our stem cell technology platform, human clinical trials in a test tube™, can provide clinically relevant predictions of potential toxicity and metabolism issues of promising new drug candidates long before they are ever tested in humans.

VTGN Stock Summary

Vistagen Therapeutics, Inc. Common Stock (NASDAQ:VTGN) stock price today is $0.3600, and today's volume is 571,374,527. VTGN is up 44.193% today. The 30 day average volume is 774,417. VTGN market cap is 16.31M with 44,376,911 shares outstanding.